Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2

A newly identified novel coronavirus (SARS-CoV-2) is causing pneumonia-associated respiratory syndrome across the world. Epidemiology, genomics, and pathogenesis of the SARS-CoV-2 show high homology with that of SARS-CoV. Current efforts are focusing on development of specific antiviral drugs. Thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Guangyu, Zhao, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098029/
https://www.ncbi.nlm.nih.gov/pubmed/32226289
http://dx.doi.org/10.7150/ijbs.45123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098029/
https://www.ncbi.nlm.nih.gov/pubmed/32226289
http://dx.doi.org/10.7150/ijbs.45123

Ejemplares similares